Fertility preservation: A key survivorship issue for young women with cancer

Frontiers in Oncology

Volumn 6, Issue APR, 2016, Pages

  Angarita, Ana Milena ^a   Johnson, Cynae A ^b   Fader, Amanda Nickles ^a   Christianson, Mindy S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Cancer survivorship; Counseling; Cryopreservation; Fertility preservation; Fertility sparing surgery

Indexed keywords

CANCER SURVIVOR; CANCER THERAPY; COUNSELING; CRYOPRESERVATION; DIAGNOSIS; DOCTOR PATIENT RELATION; EMBRYO; FERTILITY; HEALTH CARE PERSONNEL; HUMAN; HUMAN TISSUE; MEDICINE; ONCOLOGY; OOCYTE; OVARIAN TISSUE; QUALITY OF LIFE;

EID: 84973535634     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2016.00102     Document Type: Review

References (92)

1. Surveillance, Epidemiology, and End Results (SEER) Program. Cancer Statistics Review 1975-2012. (2015). Available from: http://seer.cancer.gov/csr/1975_2012/browse_csr.php
2. Keegan TH, Ries LA, Barr RD, Geiger AM, Dahlke DV, Pollock BH, et al. Comparison of cancer survival trends in the united states of adolescents and young adults with those in children and older adults. Cancer (2016) 122(7):1009-16. doi: 10.1002/cncr.29869
3. Heck KE, Schoendorf KC, Ventura SJ, Kiely JL. Delayed childbearing by education level in the united states, 1969-1994. Matern Child Health J (1997) 1(2):81-8. doi:10.1023/A:1026218322723
4. Peddie VL, Porter MA, Barbour R, Culligan D, MacDonald G, King D, et al. Factors affecting decision making about fertility preservation after cancer diagnosis: a qualitative study. BJOG (2012) 119(9):1049-57. doi:10.1111/j.1471-0528.2012.03368.x
5. Reh AE, Lu L, Weinerman R, Grifo J, Krey L, Noyes N. Treatment outcomes and quality-of-life assessment in a university-based fertility preservation program: results of a registry of female cancer patients at 2 years. J Assist Reprod Genet (2011) 28(7):635-41. doi:10.1007/s10815-011-9559-z
6. Rosen A, Rodriguez-Wallberg KA, Rosenzweig L. Psychosocial distress in young cancer survivors. Semin Oncol Nurs (2009) 25(4):268-77. doi:10.1016/j.soncn.2009.08.004
7. Benedict C, Thom B, Kelvin JF. Fertility preservation and cancer: challenges for adolescent and young adult patients. Curr Opin Support Palliat Care (2016) 10(1):87-94. doi:10.1097/SPC.0000000000000185
8. Partridge AH, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M, et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol (2004) 22(20):4174-83. doi:10.1200/JCO.2004.01.159
9. Ruddy KJ, Gelber SI, Tamimi RM, Ginsburg ES, Schapira L, Come SE, et al. Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol (2014) 32(11):1151-6. doi:10.1200/JCO.2013.52.8877
10. Schover LR. Rates of postcancer parenthood. J Clin Oncol (2009) 27(3):321-2. doi:10.1200/JCO.2008.19.7749
11. Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, et al. Fertility preservation for patients with cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol (2013) 31(19):2500-10. doi:10.1200/JCO.2013.49.2678
12. Byrne J, Fears TR, Steinhorn SC, Mulvihill JJ, Connelly RR, Austin DF, et al. Marriage and divorce after childhood and adolescent cancer. JAMA (1989) 262(19):2693-9. doi:10.1001/jama.262.19.2693
13. Geue K, Richter D, Schmidt R, Sender A, Siedentopf F, Brähler E, et al. The desire for children and fertility issues among young german cancer survivors. J Adolesc Health (2014) 54(5):527-35. doi:10.1016/j.jadohealth.2013.10.005
14. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American society of clinical oncology recommendations on fertility preservation in cancer patients. J Clin Oncol (2006) 24(18):2917-31. doi:10.1200/JCO.2006.06.5888
15. Martínez F, Devesa M, Coroleu B, Tur R, González C, Boada M, et al. Cancer and fertility preservation: Barcelona consensus meeting. Gynecol Endocrinol (2013) 29(4):285-91. doi:10.3109/09513590.2012.743019
16. Deshpande NA, Braun IM, Meyer FL. Impact of fertility preservation counseling and treatment on psychological outcomes among women with cancer: a systematic review. Cancer (2015) 121(22):3938-47. doi:10.1002/cncr.29637
17. Quinn G, Vadaparampil S. Fertility and cancer-patient, physician, and institutional barriers. US Oncol Hematol (2011) 7(1):22-4. doi:10.17925/OHR.2011.07.1.22
18. McLaren JF, Bates GW. Fertility preservation in women of reproductive age with cancer. Am J Obstet Gynecol (2012) 207(6):455-62. doi:10.1016/j.ajog.2012.08.013
19. Torino F, Barnabei A, De Vecchis L, Sini V, Schittulli F, Marchetti P, et al. Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer. Crit Rev Oncol Hematol (2014) 89(1):27-42. doi:10.1016/j.critrevonc.2013.07.007
20. Barton SE, Najita JS, Ginsburg ES, Leisenring WM, Stovall M, Weathers RE, et al. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the childhood cancer survivor study cohort. Lancet Oncol (2013) 14(9):873-81. doi:10.1016/S1470-2045(13)70251-1
21. Larsen EC, Muller J, Schmiegelow K, Rechnitzer C, Andersen AN. Reduced ovarian function in long-term survivors of radiation-and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab (2003) 88(11):5307-14. doi:10.1210/jc.2003-030352
22. Epstein RJ. Drug-induced DNA damage and tumor chemosensitivity. J Clin Oncol (1990) 8(12):2062-84
23. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update (2001) 7(6):535-43. doi:10.1093/humupd/7.6.535
24. Rodriguez-Wallberg KA, Oktay K. Fertility preservation during cancer treatment: clinical guidelines. Cancer Manag Res (2014) 6:105-17. doi:10.2147/CMAR.S32380
25. Yashar C. Basic principles in gynecologic radiotherapy. 8th ed. In: Di Saia P, Creasman W, editors. Clinical Gynecologic Oncology. Philadelphia, PA: Elsevier/Saunders (2012). p. 659-80
26. Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol (2005) 6(4):209-18. doi:10.1016/S1470-2045(05)70092-9
27. Green DM, Sklar CA, Boice JD Jr, Mulvihill JJ, Whitton JA, Stovall M, et al. Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the childhood cancer survivor study. J Clin Oncol (2009) 27(14):2374-81. doi:10.1200/JCO.2008.21.1839
28. Dillon KE, Gracia CR. Pediatric and young adult patients and oncofertility. Curr Treat Options Oncol (2012) 13(2):161-73. doi:10.1007/s11864-012-0183-7
29. Critchley HO, Wallace WH. Impact of cancer treatment on uterine function. J Natl Cancer Inst Monogr (2005) 34(34):64-8. doi:10.1093/jncimonographs/lgi022
30. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet (2009) 105(2):103-4. doi:10.1016/j.ijgo.2009.02.009
31. Prat J, FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet (2014) 124(1):1-5. doi:10.1016/j.ijgo.2013.10.001
32. Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Poynor EA, Aghajanian C, et al. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecol Oncol (2006) 103(3):1083-90. doi:10.1016/j.ygyno.2006.06.028
33. Bogani G, Dowdy SC, Cliby WA, Ghezzi F, Rossetti D, Mariani A. Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence. J Obstet Gynaecol Res (2014) 40(2):301-11. doi:10.1111/jog.12344
34. Bansal N, Herzog TJ, Shaw RE, Burke WM, Deutsch I, Wright JD. Primary therapy for early-stage cervical cancer: radical hysterectomy vs radiation. Am J Obstet Gynecol (2009) 201(5):e1-485. doi:10.1016/j.ajog.2009.06.015
35. Dolmans MM, Hollanders de Ouderaen S, Demylle D, Pirard C. Utilization rates and results of long-term embryo cryopreservation before gonadotoxic treatment. J Assist Reprod Genet (2015) 32(8):1233-7. doi:10.1007/s10815-015-0533-z
36. Das M, Shehata F, Moria A, Holzer H, Son WY, Tulandi T. Ovarian reserve, response to gonadotropins, and oocyte maturity in women with malignancy. Fertil Steril (2011) 96(1):122-5. doi:10.1016/j.fertnstert.2011.04.070
37. Quintero RB, Helmer A, Huang JQ, Westphal LM. Ovarian stimulation for fertility preservation in patients with cancer. Fertil Steril (2010) 93(3):865-8. doi:10.1016/j.fertnstert.2008.10.007
38. Domingo J, Guillén V, Ayllón Y, Martínez M, Muñoz E, Pellicer A, et al. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment. Fertil Steril (2012) 97(4):930-4. doi:10.1016/j.fertnstert.2012.01.093
39. Almog B, Azem F, Gordon D, Pauzner D, Amit A, Barkan G, et al. Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation. Fertil Steril (2012) 98(4):957-60. doi:10.1016/j.fertnstert.2012.06.007
40. Oktay K, Kim JY, Barad D, Babayev SN. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. J Clin Oncol (2010) 28(2):240-4. doi:10.1200/JCO.2009.24.2057
41. Quinn GP, Vadaparampil ST, McGowan Lowrey K, Eidson S, Knapp C, Bukulmez O. State laws and regulations addressing third-party reimbursement for infertility treatment: implications for cancer survivors. Fertil Steril (2011) 95(1):72-8. doi:10.1016/j.fertnstert.2010.05.017
42. Oktay K, Turan V, Bedoschi G, Pacheco FS, Moy F. Fertility preservation success subsequent to concurrent aromatase inhibitor treatment and ovarian stimulation in women with breast cancer. J Clin Oncol (2015) 33(22):2424-9. doi:10.1200/JCO.2014.59.3723
43. Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol (2005) 23(19):4347-53. doi:10.1200/JCO.2005.04.011
44. Cakmak H, Katz A, Cedars MI, Rosen MP. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil Steril (2013) 100(6):1673-80. doi:10.1016/j.fertnstert.2013.07.1992
45. Anderson RA, Kinniburgh D, Baird DT. Preliminary experience of the use of a gonadotrophin-releasing hormone antagonist in ovulation induction/in-vitro fertilization prior to cancer treatment. Hum Reprod (1999) 14(10):2665-8. doi:10.1093/humrep/14.10.2665
46. Bedoschi GM, de Albuquerque FO, Ferriani RA, Navarro PA. Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature. J Assist Reprod Genet (2010) 27(8):491-4. doi:10.1007/s10815-010-9429-0
47. von Wolff M, Thaler CJ, Frambach T, Zeeb C, Lawrenz B, Popovici RM, et al. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril (2009) 92(4):1360-5. doi:10.1016/j.fertnstert.2008.08.011
48. Practice Committee of American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril (2008) 90(5 Suppl):S188-93. doi:10.1016/j.fertnstert.2008.08.034
49. Practice Committees of American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril (2013) 99(1):37-43. doi:10.1016/j.fertnstert.2012.09.028
50. Boiso I, Marti M, Santalo J, Ponsa M, Barri PN, Veiga A. A confocal microscopy analysis of the spindle and chromosome configurations of human oocytes cryopreserved at the germinal vesicle and metaphase II stage. Hum Reprod (2002) 17(7):1885-91. doi:10.1093/humrep/17.7.1885
51. Matson PL, Graefling J, Junk SM, Yovich JL, Edirisinghe WR. Cryopreservation of oocytes and embryos: use of a mouse model to investigate effects upon zona hardness and formulate treatment strategies in an in-vitro fertilization programme. Hum Reprod (1997) 12(7):1550-3. doi:10.1093/humrep/12.7.1550
52. Jain JK, Paulson RJ. Oocyte cryopreservation. Fertil Steril (2006) 86(4 Suppl):1037-46. doi:10.1016/j.fertnstert.2006.07.1478
53. Papatheodorou A, Vanderzwalmen P, Panagiotidis Y, Prapas N, Zikopoulos K, Georgiou I, et al. Open versus closed oocyte vitrification system: a prospective randomized sibling-oocyte study. Reprod Biomed Online (2013) 26(6):595-602. doi:10.1016/j.rbmo.2013.02.014
54. Porcu E, Fabbri R, Seracchioli R, Ciotti PM, Magrini O, Flamigni C. Birth of a healthy female after intracytoplasmic sperm injection of cryopreserved human oocytes. Fertil Steril (1997) 68(4):724-6. doi:10.1016/S0015-0282(97)00268-9
55. Cobo A, Diaz C. Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril (2011) 96(2):277-85. doi:10.1016/j.fertnstert.2011.06.030
56. Cil AP, Bang H, Oktay K. Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis. Fertil Steril (2013) 100(2):492.e-9.e. doi:10.1016/j.fertnstert.2013.04.023
57. Rienzi L, Cobo A, Paffoni A, Scarduelli C, Capalbo A, Vajta G, et al. Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study. Hum Reprod (2012) 27(6):1606-12. doi:10.1093/humrep/des088
58. Goldman KN, Noyes NL, Knopman JM, McCaffrey C, Grifo JA. Oocyte efficiency: does live birth rate differ when analyzing cryopreserved and fresh oocytes on a per-oocyte basis? Fertil Steril (2013) 100(3):712-7. doi:10.1016/j.fertnstert.2013.04.040
59. Cobo A, Meseguer M, Remohi J, Pellicer A. Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Hum Reprod (2010) 25(9):2239-46. doi:10.1093/humrep/deq146
60. Parmegiani L, Cognigni GE, Bernardi S, Cuomo S, Ciampaglia W, Infante FE, et al. Efficiency of aseptic open vitrification and hermetical cryostorage of human oocytes. Reprod Biomed Online (2011) 23(4):505-12. doi:10.1016/j.rbmo.2011.07.003
61. Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab (2006) 91(10):3885-90. doi:10.1210/jc.2006-0962
62. Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol (2008) 26(16):2630-5. doi:10.1200/JCO.2007.14.8700
63. Practice Committee of American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril (2013) 100(5):1214-23. doi:10.1016/j.fertnstert.2013.08.012
64. Resetkova N, Hayashi M, Kolp LA, Christianson MS. Fertility preservation for prepubertal girls: update and current challenges. Curr Obstet Gynecol Rep (2013) 2(4):218-25. doi:10.1007/s13669-013-0060-9
65. Practice Committee of American Society for Reproductive Medicine. Ovarian tissue cryopreservation: a committee opinion. Fertil Steril (2014) 101(5):1237-43. doi:10.1016/j.fertnstert.2014.02.052
66. Oktem O, Oktay K. Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function. Cancer (2007) 110(10):2222-9. doi:10.1002/cncr.23071
67. Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet (2004) 364(9443):1405-10. doi:10.1016/S0140-6736(04)17222-X
68. Donnez J, Dolmans MM. Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J Assist Reprod Genet (2015) 32(8):1167-70. doi:10.1007/s10815-015-0544-9
69. Donnez J, Dolmans MM, Pellicer A, Diaz-Garcia C, Ernst E, Macklon KT, et al. Fertility preservation for age-related fertility decline. Lancet (2015) 385(9967):506-7. doi:10.1016/S0140-6736(15)60198-2
70. Wallace WH, Smith AG, Kelsey TW, Edgar AE, Anderson RA. Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation. Lancet Oncol (2014) 15(10):1129-36. doi:10.1016/S1470-2045(14)70334-1
71. Visvanathan DK, Cutner AS, Cassoni AM, Gaze M, Davies MC. A new technique of laparoscopic ovariopexy before irradiation. Fertil Steril (2003) 79(5):1204-6. doi:10.1016/S0015-0282(03)00157-2
72. Elizur SE, Tulandi T, Meterissian S, Huang JY, Levin D, Tan SL. Fertility preservation for young women with rectal cancer-a combined approach from one referral center. J Gastrointest Surg (2009) 13(6):1111-5. doi:10.1007/s11605-009-0829-3
73. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update (2004) 10(3):251-66. doi:10.1093/humupd/dmh021
74. Gabriel DA, Bernard SA, Lambert J, Croom RD III. Oophoropexy and the management of Hodgkin's disease. A reevaluation of the risks and benefits. Arch Surg (1986) 121(9):1083-5
75. Bentivegna E, Morice P, Uzan C, Gouy S. Fertility-sparing surgery in epithelial ovarian cancer. Future Oncol (2016) 12(3):389-98. doi:10.2217/fon.15.319
76. Harter P, Gershenson D, Lhomme C, Lecuru F, Ledermann J, Provencher DM, et al. Gynecologic cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors). Int J Gynecol Cancer (2014) 24(9 Suppl 3):S5-8. doi:10.1097/IGC.0000000000000282
77. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
78. Fruscio R, Corso S, Ceppi L, Garavaglia D, Garbi A, Floriani I, et al. Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series. Ann Oncol (2013) 24(1):138-44. doi:10.1093/annonc/mds241
79. Bisseling KC, Bekkers RL, Rome RM, Quinn MA. Treatment of microinvasive adenocarcinoma of the uterine cervix: a retrospective study and review of the literature. Gynecol Oncol (2007) 107(3):424-30. doi:10.1016/j.ygyno.2007.07.062
80. Wright JD, NathavithArana R, Lewin SN, Sun X, Deutsch I, Burke WM, et al. Fertility-conserving surgery for young women with stage IA1 cervical cancer: safety and access. Obstet Gynecol (2010) 115(3):585-90. doi:10.1097/AOG.0b013e3181d06b68
81. Johansen G, Lönnerfors C, Falconer H, Persson J. Reproductive and oncologic outcome following robot-assisted laparoscopic radical trachelectomy for early stage cervical cancer. Gynecol Oncol (2016) 141(1):160-5. doi:10.1016/j.ygyno.2016.01.028
82. Shepherd JH, Spencer C, Herod J, Ind TE. Radical vaginal trachelectomy as a fertility-sparing procedure in women with early-stage cervical cancer-cumulative pregnancy rate in a series of 123 women. BJOG (2006) 113(6):719-24. doi:10.1111/j.1471-0528.2006.00936.x
83. ClinicalTrials.gov. (2016). Available from: https://clinicaltrials.gov/ct2/show/record/NCT01048853
84. Gunderson CC, Fader AN, Carson KA, Bristow RE. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol (2012) 125(2):477-82. doi:10.1016/j.ygyno.2012.01.003
85. Shnorhavorian M, Harlan LC, Smith AW, Keegan TH, Lynch CF, Prasad PK, et al. Fertility preservation knowledge, counseling, and actions among adolescent and young adult patients with cancer: a population-based study. Cancer (2015) 121(19):3499-506. doi:10.1002/cncr.29328
86. Klock SC, Zhang JX, Kazer RR. Fertility preservation for female cancer patients: early clinical experience. Fertil Steril (2010) 94(1):149-55. doi:10.1016/j.fertnstert.2009.03.028
87. Baynosa J, Westphal LM, Madrigrano A, Wapnir I. Timing of breast cancer treatments with oocyte retrieval and embryo cryopreservation. J Am Coll Surg (2009) 209(5):603-7. doi:10.1016/j.jamcollsurg.2009.08.006
88. Lee S, Ozkavukcu S, Heytens E, Moy F, Oktay K. Value of early referral to fertility preservation in young women with breast cancer. J Clin Oncol (2010) 28(31):4683-6. doi:10.1200/JCO.2010.30.5748
89. Thewes B, Meiser B, Rickard J, Friedlander M. The fertility-and -menopause-related information needs of younger women with a diagnosis of breast cancer: a qualitative study. Psychooncology (2003) 12(5):500-11. doi:10.1002/pon.685
90. Meneses K, McNees P, Azuero A, Jukkala A. Development of the fertility and cancer project: an internet approach to help young cancer survivors. Oncol Nurs Forum (2010) 37(2):191-7. doi:10.1188/10.ONF.191-197
91. Campo-Engelstein L. For the sake of consistency and fairness: why insurance companies should cover fertility preservation treatment for iatrogenic infertility. Cancer Treat Res (2010) 156:381-8. doi:10.1007/978-1-4419-6518-9_29
92. The Livestrong Foundation. Available from: http://www.livestrong.org/we-can-help/fertility-services/fertility-women/